Gabagaya, Grace
Rukundo, Gordon
Amone, Alexander
Wavamunno, Priscilla
Namale-Matovu, Joyce
Lubega, Irene
Nakabiito, Clemensia
Namukwaya, Zikulah
Nolan, Monica
Malamba, Samuel S.
King, Rachel
Homsy, Jaco
Fowler, Mary Glenn
Musoke, Philippa
Clinical trials referenced in this document:
Documents that mention this clinical trial
Prevalence of undetectable and suppressed viral load in HIV-infected pregnant women initiating Option B+ in Uganda: an observational study nested within a randomized controlled trial
https://doi.org/10.1186/s12879-021-06608-4
Article History
Received: 15 April 2021
Accepted: 17 August 2021
First Online: 4 September 2021
Declarations
:
: All study procedures were conducted in compliance with the relevant national laws and international regulatory requirements. Written informed consent was obtained from all study participants prior to any protocol-specified procedures being conducted. The study protocol, informed consent forms, and other study instruments administered to participants were reviewed and approved by the Joint Clinical Research Centre (JCRC) Institutional Review Board in Uganda; the Uganda National Council for Science and Technology (UNCST), Johns Hopkins University (JHU) and University of California San Francisco (UCSF) Ethics committees prior to participant enrolment or study procedures.
: Not applicable.
: The authors declare that they have no competing interests.